Document Detail

Methods of the pharmacological imaging of the cannabinoid system (PhICS) study: towards understanding the role of the brain endocannabinoid system in human cognition.
MedLine Citation:
PMID:  21574207     Owner:  NLM     Status:  MEDLINE    
Various lines of (pre)clinical research indicate that cannabinoid agents carry the potential for therapeutic application to reduce symptoms in several psychiatric disorders. However, direct testing of the involvement of cannabinoid brain systems in psychiatric syndromes is essential for further development. In the Pharmacological Imaging of the Cannabinoid System (PhICS) study, the involvement of the endocannabinoid system in cognitive brain function is assessed by comparing acute effects of the cannabinoid agonist Δ9-tetrahydrocannabinol (THC) on brain function between healthy controls and groups of psychiatric patients showing cognitive dysfunction. This article describes the objectives and methods of the PhICS study and presents preliminary results of the administration procedure on subjective and neurophysiological parameters. Core elements in the methodology of PhICS are the administration method (THC is administered by inhalation using a vaporizing device) and a comprehensive use of pharmacological magnetic resonance imaging (phMRI) combining several types of MRI scans including functional MRI (fMRI), Arterial Spin Labeling (ASL) to measure brain perfusion, and resting-state fMRI. Additional methods like neuropsychological testing further specify the exact role of the endocannabinoid system in regulating cognition. Preliminary results presented in this paper indicate robust behavioral and subjective effects of THC. In addition, fMRI paradigms demonstrate activation of expected networks of brain regions in the cognitive domains of interest. The presented administration and assessment protocol provides a basis for further research on the involvement of the endocannabionoid systems in behavior and in psychopathology, which in turn may lead to development of therapeutic opportunities of cannabinoid ligands.
Hendrika H van Hell; Matthijs G Bossong; Gerry Jager; René S Kahn; Nick F Ramsey
Related Documents :
18290217 - A digital hardware correlation system for fast ultrasonic data acquisition in peak powe...
22929357 - Clinical photography in the dermatology practice.
12726937 - A conical air-coupled capacitance transducer for surface imaging.
18263167 - Electronic scanning in ultrasonic imaging using a wedge transducer.
17270847 - Determining deformation resistance in cutting soft tissue with nonuniform thickness.
22253707 - Evidence for a grooming claw in a north american adapiform primate: implications for an...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of methods in psychiatric research     Volume:  20     ISSN:  1557-0657     ISO Abbreviation:  Int J Methods Psychiatr Res     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-05-16     Completed Date:  2011-09-30     Revised Date:  2014-03-25    
Medline Journal Info:
Nlm Unique ID:  9111433     Medline TA:  Int J Methods Psychiatr Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  10-27     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 John Wiley & Sons, Ltd.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Analysis of Variance
Attention / drug effects
Brain / blood supply*,  drug effects,  metabolism*
Brain Mapping*
Cannabinoid Receptor Modulators / metabolism*
Cognition / drug effects,  physiology*
Double-Blind Method
Dronabinol / blood,  therapeutic use
Emotions / drug effects
Heart Rate / drug effects
Image Processing, Computer-Assisted
Magnetic Resonance Imaging / methods
Mental Disorders / blood,  drug therapy,  pathology,  physiopathology
Neuropsychological Tests
Oxygen / blood
Pain Measurement
Personality / drug effects
Psychotropic Drugs / blood,  therapeutic use
Randomized Controlled Trials as Topic
Spin Labels
Time Factors
Reg. No./Substance:
0/Cannabinoid Receptor Modulators; 0/Endocannabinoids; 0/Psychotropic Drugs; 0/Spin Labels; 7J8897W37S/Dronabinol; S88TT14065/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The statistical pitfalls of the partially randomized preference design in non-blinded trials of psyc...
Next Document:  Smoking cessation in primary care - a randomized controlled trial of bupropione, nicotine replacemen...